- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 471/12
Total number of patents in this class: 180
10-year publication summary
|
19
|
19
|
8
|
5
|
10
|
9
|
16
|
12
|
13
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3392 |
6 |
| LG Chem, Ltd. | 17615 |
4 |
| Merck Patent GmbH | 5828 |
4 |
| ChemoCentryx, Inc. | 386 |
4 |
| Senhwa Biosciences, Inc. | 38 |
4 |
| Bristol-myers Squibb Company | 4875 |
3 |
| BASF SE | 20912 |
3 |
| Takeda Pharmaceutical Company Limited | 2714 |
3 |
| Oncoceutics, Inc. | 29 |
3 |
| Owens Corning Intellectual Capital, LLC | 1634 |
3 |
| Tel Hashomer Medical Research Infrastructure and Services Ltd. | 330 |
3 |
| Neuron23, Inc. | 25 |
3 |
| Acerand Therapeutics (Hong Kong) Limited | 11 |
3 |
| Novartis AG | 10856 |
2 |
| Syngenta Crop Protection AG | 6057 |
2 |
| Abbvie Inc. | 1805 |
2 |
| BeiGene, Ltd. | 366 |
2 |
| Chimerix, Inc. | 89 |
2 |
| Deciphera Pharmaceuticals, LLC | 217 |
2 |
| Eli Lilly and Company | 3840 |
2 |
| Other owners | 120 |